Rheinmetall Drops Its Cash Target Just as the Arminius Order Slips Into 2027
Published on 11/05/2026 at 22:02 | Editorial boerse-global.de
Rheinmetall's shares fell 12% on Wednesday, a day after the defence group trimmed its full-year guidance for the second time in three months — and the sell-off came despite a set of quarterly figures that one broker called strong.
The trigger was Tuesday's downgrade: revenue for 2026 is now expected at around EUR 13.2bn, down from a prior range of EUR 13.7–14.2bn, with the operating margin guided to roughly 18.5% instead of about 19%. Rheinmetall pointed to likely delays on the Arminius-Boxer order and on lot acceptances for artillery ammunition. The Arminius contract is no longer expected this year at all, and revenue from the postponed ammunition deliveries shifts into 2027.
A third-quarter beat overshadowed by the outlook
For the three months to September, Rheinmetall posted an operating result of EUR 553m, up 62%, on revenue of EUR 3.149bn and an operating margin of 17.5%. Order intake came in at EUR 2.893bn. Across the first nine months of 2026, revenue reached EUR 8.4bn — growth of 38% — while the operating result climbed 69% to EUR 1.34bn.
RBC's Colin Moody kept an "Outperform" rating and a EUR 1,600 price target, describing the quarterly numbers as strong but clouded by the weakened annual outlook. JPMorgan's David Perry, who had anticipated a sharp share price reaction after the profit warning, cut his target to EUR 1,150 from EUR 1,350 and stayed at "Neutral".
Should investors sell immediately? Or is it worth buying Rheinmetall?
The cash-conversion target quietly disappears
Alongside the guidance cut, Rheinmetall scrapped its target of a cash-conversion rate above 40%, according to Reuters. That decision shifts the question for investors from whether growth is arriving to whether it can be turned into liquid funds. Operating free cash flow stood at minus EUR 82m in the third quarter of 2026, and management still expects a positive figure for the full year — though a positive inflow would not by itself amount to a return to the old conversion goal.
The distinction matters because the delays operate on two different levels. The Arminius-Boxer award, including advance payments, is now expected to slip into the following year, while artillery ammunition is a case of delayed acceptances rather than a missing contract. Add capital expenditure still guided above EUR 1bn for 2026, and the test becomes whether growth is merely profitable or actually generates enough cash to fund its own expansion.
Two readings of the same shortfall
Citi's Charles Armitage takes the constructive view, judging that most of the shortfall has been deferred rather than lost. He reiterated his Buy rating while lowering his price target to EUR 1,374. That stance is not confirmation that the payments will arrive — it describes the condition for a recovery: the economic substance of the expected business has to hold while Rheinmetall proves it can execute.
JPMorgan's Perry frames the other side, pointing to the fifth revenue or earnings warning in eleven months. His concern goes beyond a single delay. He sees unclear revenue prospects for some land-systems products and questions the targets attached to the planned joint ventures. Should expected proceeds come in lower rather than later, the pure timing argument would fall short.
The Destinus cooperation is another open flank. Expected revenue could fail to materialise or arrive late, and following Destinus's agreements with Helsing, a deal is viewed as less certain. Not every deviation therefore rests solely on the timing of government procurement decisions.
Rheinmetall at a turning point? This analysis reveals what investors need to know now.
What the capital markets day must deliver
Rheinmetall has announced a Capital Markets Day for 26–27 November, with the company's own release naming 27 November 2026. That event is now the next concrete checkpoint. Investors will want to see medium-term targets underpinned by contract positions, acceptance schedules and funding needs; repeating ambitious growth goals would leave the open questions unanswered.
Also in focus are the existing 2030 ambitions: revenue of around EUR 50bn and an operating margin above 20%. No reduction has been agreed. JPMorgan, however, considers a substantial revision likely — which makes the credibility of the path to those targets more important than their headline size.
As long as the expected business survives and Rheinmetall delivers positive cash inflows, the catch-up scenario remains plausible. If order volumes or the economics behind the cooperations deteriorate, investors would have to reassess longer-term earnings and cash forecasts far more critically.
Ad
Rheinmetall Stock: New Analysis - 5 November
Fresh Rheinmetall information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
